chartexchange

bioAffinity Technologies Reports Record Monthly Testing Volume in October for Its Noninvasive CyPath® Lung Test

Business Wire | Nov 11, 2026 8:00 AM EST

SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity reports record monthly testing volume for the Company's noninvasive lung cancer test CyPath Lung.

Read original article